AstraZeneca to invest $2.5 bn in new R&D centre, biotech agreements and manufacturing in…
In addition, AstraZeneca is launching a new joint venture with BioKangtai, to develop, manufacture, and commercialise innovative…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Deals
Syngene concludes acquisition of Emergent BioSolutions’ biologics manufacturing facility
The new site will increase Syngene’s total single-use bioreactor capacity to 50,000L for large molecule discovery, development,…
Cipla, Formosa sign multi-regional licensing deal for Clobetasol Suspension
This partnership aims to enhance ophthalmic care by providing treatment for post- operative inflammation and pain in patients…
Shilpa Biologicals partners with mAbTree Biologics for novel immuno-oncology asset
Shilpa to undertake both development and commercial supply for mAbTree’s novel checkpoint inhibitor
Peptris Technologies out-licenses AI-discovered drug candidate to Revio Therapeutics
Under the agreement, Revio Therapeutics will hold commercialisation rights to PEPR124 (RT001) in all markets except in BRICS…
AstraZeneca to acquire EsoBiotec to advance cell therapy ambition
EsoBiotec will become a wholly owned subsidiary of AstraZeneca, with operations in Belgium
India and Belgium unite to advance RNA-based vaccines
As part of this collaboration, TechInvention is introducing Quantoom’s RNA manufacturing solutions—to India with a focus on…
Senores Pharma acquires 14 ANDAs from Dr. Reddy’s
The basket acquired comprises 13 ANDAs, which are approved by the USFDA and 1 ANDA, which is pending approval from the USFDA
Sun Pharma subsidiary Taro acquires Antibe Therapeutics
Antibe Therapeutics is a clinical-stage biotechnological company based in Ontario, Canada
Deal value declined by 86.4 per cent in Dec 2024, compared to Dec 2023
Three major deals contributed 70 per cent of the total deal value during December 2024
Lupin acquires Huminsulin from Eli Lilly
Lupin has been marketing the Huminsulin range of products through existing distribution and promotion agreements with Lilly, India…
Akums Group enters into a partnership for European market expansion
Under this collaboration, Akums Group will produce and supply multiple SKUs of oral liquid formulations, which the partner company…
Prothix LifeSciences partners with Oviya MedSafe
This partnership formalised through an MoU aims to leverage the business synergies between the two organisations to deliver…
Power Gummies raises ₹10 cr, aims to expand product range
The funding would be used to launch a zero-sugar range, upgrade compositions to make the brand sugar-free and diversify into…
Asahi Kasei Pharma enters into exclusive license agreement for anti-CX3CR1 Antibody
The anti-CX3CR1 antibody, currently in preclinical development, works by inhibiting CX3CR1, a receptor involved in immune cell…
M&A in pharma sees deals worth $14.8 bn in Nov 2024
According to GlobalData, M&A deal value declined by 2 per cent, and venture capital investments decreased by 5 per cent in…
Akums, Jagdale partner to manufacture aseptic carton packing for ready-to-drink nutritional…
The partnership aims to introduce non-milk-based aseptic carton packing solutions across key categories
Merck Life Science in India, Department for Promotion of Industry and Internal Trade sign an MoU
This collaboration under DPIIT's Startup India initiative aims to empower emerging biotech startups and provide access to global…
Merck Life Science in India, GeNext Genomics sign MoU
This collaboration aims to combine local expertise with global biomanufacturing capabilities
STEERLife and Callidus Research Laboratories partner to accelerate drug development
The collaboration combines STEERLife's advanced hot melt extrusion (HME) and continuous processing technologies with Callidus'…